Viread Science Korea release positive clinical results on Viread

Published: 2013-06-17 06:58:00

Updated: 2013-06-17 06:58:00

Viread Science Korea Thursday announced new data from follow-up studies in China, Korea and Europe, which compared Viread (tenofovir disoproxil fumarate) to Hepsera (adefovir dipivoxil) over 48 weeks of treatment among primarily treatment-naive patients with chronic hepatitis B virus (HBV) infection.

According to new study results presented at the annual meeting of Asia Pacific Association f...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.